Sallis–Beighton syndrome
Sallis–Beighton syndrome is a rare genetic disorder that affects multiple systems of the body. It is characterized by a combination of symptoms and physical findings that may vary greatly in range and severity from case to case. The syndrome is named after the researchers who first described it.
Symptoms and Characteristics[edit | edit source]
Sallis–Beighton syndrome is primarily known for its impact on the connective tissue, leading to symptoms such as hypermobility of the joints, skin that may be stretchy and fragile, and a tendency towards bruising easily. Individuals with this syndrome may also exhibit features that overlap with other connective tissue disorders, making diagnosis challenging.
Genetic Aspect[edit | edit source]
The exact genetic mutation responsible for Sallis–Beighton syndrome has not been fully identified, making it difficult to understand the inheritance pattern. However, it is believed to be autosomal dominant, meaning that only one copy of the altered gene in each cell is sufficient to cause the disorder. This suggests that a person with Sallis–Beighton syndrome has a 50% chance of passing the condition on to their offspring.
Diagnosis[edit | edit source]
Diagnosis of Sallis–Beighton syndrome is primarily clinical, based on the presence of characteristic symptoms and family history. Genetic testing may be helpful in confirming the diagnosis but is not always conclusive due to the current limitations in understanding the genetic basis of the syndrome.
Treatment and Management[edit | edit source]
There is no cure for Sallis–Beighton syndrome, and treatment is symptomatic and supportive. Management may include physical therapy to strengthen muscles and improve joint stability, as well as measures to protect the skin and prevent injury. In some cases, surgery may be necessary to correct joint problems or other physical abnormalities associated with the syndrome.
Prognosis[edit | edit source]
The prognosis for individuals with Sallis–Beighton syndrome varies depending on the severity of symptoms and the effectiveness of management strategies. With appropriate care, most individuals can lead active, fulfilling lives.
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD